These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4828723)

  • 1. Ophthalmic bioavailability. I. Corneal penetration of aceclidine (3-acetoxyquinuclidine) into the rabbit eye using a perfusion technique.
    Brian B; Boltralik JJ; Thom L; Zeleznick LD
    J Pharm Sci; 1974 Apr; 63(4):633-5. PubMed ID: 4828723
    [No Abstract]   [Full Text] [Related]  

  • 2. Ocular penetration of topically applied mannitol.
    Lazar M; Nowakowski J; Furman M; Shore B
    Am J Ophthalmol; 1970 Nov; 70(5):849-51. PubMed ID: 5477174
    [No Abstract]   [Full Text] [Related]  

  • 3. Preparation of ophthalmic formulations containing cilostazol as an anti-glaucoma agent and improvement in its permeability through the rabbit cornea.
    Okamoto N; Ito Y; Nagai N; Murao T; Takiguchi Y; Kurimoto T; Mimura O
    J Oleo Sci; 2010; 59(8):423-30. PubMed ID: 20625234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the corneal epithelium on the intraocular penetration of fluoroquinolone ophthalmic solution.
    Fukuda M; Inoue A; Sasaki K; Takahashi N
    Jpn J Ophthalmol; 2004; 48(2):93-6. PubMed ID: 15060787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative intraocular penetration of 4 fluoroquinolones after topical instillation.
    Chung JL; Lim EH; Song SW; Kim BY; Lee JH; Mah FS; Seo KY
    Cornea; 2013 Jul; 32(7):1046-51. PubMed ID: 23615274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon and residual In.Cn in rabbit eyes following topical or subconjunctival application of the polynucleotide.
    Sawicki L; Chowchuvech E; Weissenbacher M; Galin MA
    Can J Ophthalmol; 1973 Oct; 8(4):569-74. PubMed ID: 4751905
    [No Abstract]   [Full Text] [Related]  

  • 7. Bioavailability of timolol and aceclidine after ocular instillation in the rabbit.
    Matera MG; Lampa E; Imperatore A; Berrino L; Russo F; Boldrini E; Rossi F
    Res Commun Mol Pathol Pharmacol; 1998 Apr; 100(1):35-42. PubMed ID: 9644717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aceclidine, a new pressure descreasing miotic. Pharmacological and Clinical studies].
    Bastide P; Tronche P; Rouher F
    Arzneimittelforschung; 1968 Mar; 18(3):322-4. PubMed ID: 5696008
    [No Abstract]   [Full Text] [Related]  

  • 9. Cornea preparation for in vitro bio-pharmaceutical evaluation of ophthalmic dosage forms.
    Barrelet J; Tsacopoulos M; Buri P
    J Pharm Pharmacol; 1975 Dec; 27(12):919-22. PubMed ID: 2663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transcorneal penetration of commercial ophthalmic formulations containing timolol maleate in rabbit eyes.
    Fukuda M; Sasaki H
    J Ocul Pharmacol Ther; 2015 Feb; 31(1):57-60. PubMed ID: 25303115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular penetration of topical Delta9-tetrahydrocannabinol from rabbit corneal or cul-de-sac application site.
    Green KE; Kearse CE
    Curr Eye Res; 2000 Jul; 21(1):566-70. PubMed ID: 11035538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corneal and scleral penetration studies of 6-hydroxyethoxy-2-benzothiazole sulfonamide: a topical carbonic anhydrase inhibitor.
    Kao KD; Lu DW; Chiang CH; Huang HS
    J Ocul Pharmacol; 1990; 6(4):313-20. PubMed ID: 2097315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corneal absorption of fluorometholone in rabbits. A comparative evaluation of corneal drug transport characteristics in anesthetized and unanesthetized rabbits.
    Sieg JW; Robinson JR
    Arch Ophthalmol; 1974 Sep; 92(3):240-3. PubMed ID: 4851189
    [No Abstract]   [Full Text] [Related]  

  • 14. Importance of the noncorneal absorption route in topical ophthalmic drug delivery.
    Ahmed I; Patton TF
    Invest Ophthalmol Vis Sci; 1985 Apr; 26(4):584-7. PubMed ID: 3884542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular bioavailability of ciprofloxacin in sustained release formulations.
    Ke TL; Cagle G; Schlech B; Lorenzetti OJ; Mattern J
    J Ocul Pharmacol Ther; 2001 Dec; 17(6):555-63. PubMed ID: 11777179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative effect of antiglaucoma preparations on brain bioelectrical activity].
    Mashkovskiĭ MD; Roshchina LF
    Farmakol Toksikol; 1983; 46(1):23-8. PubMed ID: 6130969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular absorption and metabolism of topically applied epinephrine and a dipivalyl ester of epinephrine.
    Wei CP; Anderson JA; Leopold I
    Invest Ophthalmol Vis Sci; 1978 Apr; 17(4):315-21. PubMed ID: 640779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular surface distribution and pharmacokinetics of a novel ophthalmic 1% azithromycin formulation.
    Akpek EK; Vittitow J; Verhoeven RS; Brubaker K; Amar T; Powell KD; Boyer JL; Crean C
    J Ocul Pharmacol Ther; 2009 Oct; 25(5):433-9. PubMed ID: 19857105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic studies on transcorneal permeation of pilocarpine.
    Sieg JW; Robinson JR
    J Pharm Sci; 1976 Dec; 65(12):1816-22. PubMed ID: 1032669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability.
    Adelli GR; Bhagav P; Taskar P; Hingorani T; Pettaway S; Gul W; ElSohly MA; Repka MA; Majumdar S
    Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2167-2179. PubMed ID: 28399267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.